Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Thyroid associated orbitopathy--medication, radioiodine or operation?

Czarnywojtek A, Zgorzalewicz-Stachowiak M, Stangierski A, Florek E, Zdanowska J, Katarzyna H, Andrzejewska M, Ruchała M.

Przegl Lek. 2012;69(10):1140-3. Review.

PMID:
23421110
2.

Endocrine ophthalmopathy and radioiodine therapy.

Karlsson FA.

Acta Oncol. 2006;45(8):1046-50.

PMID:
17118837
3.

Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?

Salvatore D, Fenzi G.

Nat Clin Pract Endocrinol Metab. 2006 Apr;2(4):194-5. No abstract available.

PMID:
16932282
4.

Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.

Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A.

N Engl J Med. 1998 Jan 8;338(2):73-8.

5.

Radioiodine therapy and thyroid-associated orbitopathy: risk factors and preventive effects of glucocorticoids.

Dietlein M, Dederichs B, Weigand A, Schicha H.

Exp Clin Endocrinol Diabetes. 1999;107 Suppl 5:S190-4. Review.

PMID:
10614920
6.

Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey.

Weetman AP, Wiersinga WM.

Clin Endocrinol (Oxf). 1998 Jul;49(1):21-8.

PMID:
9797843
7.

Cigarette smoking and treatment outcomes in Graves ophthalmopathy.

Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell'Unto E, Bartolomei MP, Nardi M, Martino E, Pinchera A.

Ann Intern Med. 1998 Oct 15;129(8):632-5.

PMID:
9786811
8.

Grave's Eye disease developing following radioiodine treatment for toxic nodular goitre.

Tahrani AA, Rangan S, Moulik P.

Exp Clin Endocrinol Diabetes. 2007 Jul;115(7):471-3.

PMID:
17647147
9.

Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis.

Vannucchi G, Campi I, Covelli D, Dazzi D, Currò N, Simonetta S, Ratiglia R, Beck-Peccoz P, Salvi M.

J Clin Endocrinol Metab. 2009 Sep;94(9):3381-6. doi: 10.1210/jc.2009-0506. Epub 2009 Jun 30.

PMID:
19567525
10.

Graves' ophthalmopathy and 131I therapy.

Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Mazzi B, Rocchi R, Barbesino G, Pinchera A.

Q J Nucl Med. 1999 Dec;43(4):307-12. Review.

PMID:
10731781
11.

[Graves' orbitopathy].

Balázs C.

Orv Hetil. 2006 Jun 4;147(22):1011-7. Review. Hungarian.

PMID:
16913090
12.

[Ablative therapy for immune hyperthyroidism in patients with ophthalmopathy].

Lind P.

Acta Med Austriaca. 2001;28(4):105-7. German.

PMID:
11593892
13.

[Thyroid associated orbitopathy: from diagnosis to treatment].

Hamédani M, Obéric A.

Rev Med Suisse. 2013 Jan 9;9(368):66-71. Review. French.

PMID:
23367708
14.
15.

Clinical practice. Graves' ophthalmopathy.

Bartalena L, Tanda ML.

N Engl J Med. 2009 Mar 5;360(10):994-1001. doi: 10.1056/NEJMcp0806317. Review. No abstract available.

PMID:
19264688
16.

Optimal management of Graves orbitopathy: a multidisciplinary approach.

Soeters MR, van Zeijl CJ, Boelen A, Kloos R, Saeed P, Vriesendorp TM, Mourits MP.

Neth J Med. 2011 Jul-Aug;69(7):302-8. Review.

17.

Prevention of Graves' ophthalmopathy.

Bartalena L.

Best Pract Res Clin Endocrinol Metab. 2012 Jun;26(3):371-9. doi: 10.1016/j.beem.2011.09.004. Review.

PMID:
22632372
18.

Development of Graves' ophthalmopathy and uveitis after radioiodine therapy for Graves' disease in a patient with HTLV-I associated myelopathy (HAM).

Ozawa Y, Migita M, Watanabe T, Okuda I, Takeshita A, Takagi A, Shishiba Y.

Intern Med. 1994 Sep;33(9):564-8.

19.

[Treatment of Grave's ophthalmopathy with high doses of corticosteroids].

Cirić J, Zarković M, Stojanović M, Pepenezić Z, Randjelović G, Gligorović M, Trbojević B, Drezgić M, Nesović M.

Srp Arh Celok Lek. 2000 May-Jun;128(5-6):179-83. Serbian.

PMID:
11089418
20.

[Radioiodine therapy of immune hyperthyroidism depending on age. A tenable risk even for younger patients?].

Becker W, Börner W, Reiners C, Roedler HD.

Dtsch Med Wochenschr. 1988 Jun 10;113(23):954-61. Review. German. No abstract available.

PMID:
2454185

Supplemental Content

Support Center